BR0110943A - Derivados de dissulfeto úteis para o tratamento de doenças alérgicas - Google Patents

Derivados de dissulfeto úteis para o tratamento de doenças alérgicas

Info

Publication number
BR0110943A
BR0110943A BR0110943-0A BR0110943A BR0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A
Authority
BR
Brazil
Prior art keywords
treatment
disulfide derivatives
allergic diseases
derivatives useful
useful
Prior art date
Application number
BR0110943-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Zixia Feng
Mark R Hellberg
Steven T Miller
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0110943A publication Critical patent/BR0110943A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR0110943-0A 2000-05-19 2001-04-25 Derivados de dissulfeto úteis para o tratamento de doenças alérgicas BR0110943A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582700P 2000-05-19 2000-05-19
PCT/US2001/013331 WO2001090060A1 (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases

Publications (1)

Publication Number Publication Date
BR0110943A true BR0110943A (pt) 2004-01-06

Family

ID=22763799

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110943-0A BR0110943A (pt) 2000-05-19 2001-04-25 Derivados de dissulfeto úteis para o tratamento de doenças alérgicas

Country Status (19)

Country Link
US (3) US6492552B2 (enExample)
EP (1) EP1282599B1 (enExample)
JP (1) JP2003534318A (enExample)
KR (1) KR20030007589A (enExample)
CN (2) CN1241912C (enExample)
AR (1) AR028566A1 (enExample)
AT (1) ATE330938T1 (enExample)
AU (2) AU2001255675B2 (enExample)
BR (1) BR0110943A (enExample)
CA (1) CA2407964A1 (enExample)
CY (1) CY1105164T1 (enExample)
DE (1) DE60120961T2 (enExample)
DK (1) DK1282599T3 (enExample)
ES (1) ES2261402T3 (enExample)
MX (1) MXPA02011481A (enExample)
PL (1) PL365457A1 (enExample)
PT (1) PT1282599E (enExample)
WO (1) WO2001090060A1 (enExample)
ZA (1) ZA200208840B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222370T3 (es) * 2000-05-19 2005-02-01 Alcon Inc. Derivados de disulfuro de anilina para tratar enfermedades alergicas.
AU2003259007A1 (en) 2002-10-31 2004-05-25 Amersham Biosciences Ab Use of urea variants as affinity ligands
MXPA06014648A (es) * 2004-06-28 2007-02-12 Alcon Inc Formulaciones topicas para tratar pacedimientos alergicos.
ATE421547T1 (de) * 2004-12-22 2009-02-15 California Inst Of Techn Abbaubare polymere und herstellungsverfahren dafür
WO2012174478A2 (en) * 2011-06-17 2012-12-20 Halozyme, Inc. Stable formulations of a hyaluronan-degrading enzyme
US9993529B2 (en) 2011-06-17 2018-06-12 Halozyme, Inc. Stable formulations of a hyaluronan-degrading enzyme
FR3057264B1 (fr) * 2016-10-12 2020-05-29 Arkema France Composes porteurs de groupes associatifs azotes
CN108586299B (zh) * 2018-06-06 2020-06-16 北京化工大学 一种可引发、聚合及降低体积收缩的芳香二硫化合物的制备方法及用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (enExample) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0062827B1 (en) * 1978-06-16 1986-07-23 Kyowa Hakko Kogyo Co., Ltd Novel benzamide derivatives
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH095926A (ja) * 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Cetp活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 3,3’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
US20020193633A1 (en) 2002-12-19
ZA200208840B (en) 2003-12-02
EP1282599B1 (en) 2006-06-21
HK1050185A1 (en) 2003-06-13
AR028566A1 (es) 2003-05-14
WO2001090060A1 (en) 2001-11-29
DE60120961T2 (de) 2006-11-16
DK1282599T3 (da) 2006-07-31
US6506802B2 (en) 2003-01-14
ATE330938T1 (de) 2006-07-15
EP1282599A1 (en) 2003-02-12
CY1105164T1 (el) 2010-03-03
CN1241912C (zh) 2006-02-15
CN1616422A (zh) 2005-05-18
CN1429209A (zh) 2003-07-09
US20020058709A1 (en) 2002-05-16
PL365457A1 (en) 2005-01-10
AU5567501A (en) 2001-12-03
ES2261402T3 (es) 2006-11-16
US6492552B2 (en) 2002-12-10
AU2001255675B2 (en) 2005-04-14
US6500864B1 (en) 2002-12-31
US20020193634A1 (en) 2002-12-19
CN1175807C (zh) 2004-11-17
JP2003534318A (ja) 2003-11-18
KR20030007589A (ko) 2003-01-23
MXPA02011481A (es) 2003-06-06
PT1282599E (pt) 2006-08-31
DE60120961D1 (de) 2006-08-03
CA2407964A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
BR0314319A (pt) Transferência de gene mediada por vetor lentiviral e usos da mesma
CY1112444T1 (el) Χρηση των παραγωγων σουλφαμιδιου βενζο-συντηγμενου ετεροκυκλου ως νευροπροστατευτικοι παραγοντες
BR0310100A (pt) métodos para tratar, prevenir ou reduzir a lesão de reperfusão isquêmica em um tecido ou órgão, e para prevenir ou tratar de uma condição associada com a privação de oxigênio, seguida por suprimento de oxigênio aumentado a um tecido ou órgão em necessidade disto
BRPI0401768A (pt) Método de tratamento de um animal não-humano, e, método para reduzir a ocorrência de febre de transporte de gado bovino
BR9908967A (pt) Processos para reprimir, retardar ou de outro modo reduzir a expressão de um gene alvo em uma célula, tecido ou órgão e para conferir resistência ou imunidade a um patógeno viral sobre uma célula, tecido, órgão ou organismo inteiro, gene sintético capaz de reprimir, retardar ou de outro modo reduzir a expressão de um gene alvo de uma célula, tecido, órgão ou organismo inteiro, construção de gene, uso da mesma, e, célula, tecido, órgão ou organismo inteiro
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
BRPI0502346A (pt) processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
BR0316776A (pt) Formula para anti-infeccioso tópico
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
BR9714677A (pt) "enantiÈmeros 3-piridila e seu uso como analgésicos"
BR0209922A (pt) Método para tratar uma condição médica que envolve a angiogênese em um paciente, para inibir a vascularização de células endoteliais, e para tratar câncer em um mamìfero
BRPI0410419A (pt) tratamento para a ansiedade com ziprasidona
DE59906391D1 (de) Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
MX232591B (es) Procedimiento para tratar infecciones oculares con azitromicina
NO20050718L (no) Topikal behandling av hudsykdommer
WO2007095613A3 (en) Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
CY1105164T1 (el) Παραγωγα δισουλφιδιου χρησιμα για θepαπεια αλλepγικων ασθενειων
BR0110845A (pt) Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas
EP1478660A4 (en) KAPPA-PVIIA-RELATED CONOTOXINS AS ORGAN PROTECTIVE AGENTS
CN205698232U (zh) 异形硅凝胶泡沫敷料
BR0004813A (pt) Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori
BR0110852A (pt) Composições que contêm um derivado dissulfeto de benzamida para tratamento de doenças alérgicas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.